Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “chimeric”

309 pharma patents match "chimeric" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 309
Index total 30,257
Page 8 / 13

Quick answer

This filtered view shows 309 pharmaceutical patents matching "chimeric" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

309 results for “chimeric” · 30,257 patents in full index Clear search

  1. US 10800854

    Chimeric cytokine receptors and encoding nucleic acids

    AUTOLUS LIMITED · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted

  2. US 10800855

    Chimeric cytokine receptors and encoding nucleic acids

    AUTOLUS LIMITED · Granted Oct 13, 2020 · Expires Oct 8, 2040

    granted

  3. US 10767184

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Sep 8, 2020 · Expires Sep 3, 2040

    granted

  4. US 10738313

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted

  5. US 10738116

    Dual specific anti-CD22-anti-CD19 chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted

  6. US 10738312

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 11, 2020 · Expires Aug 6, 2040

    granted

  7. US 10730925

    Chimeric polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same

    Protalix Ltd. · Granted Aug 4, 2020 · Expires Jul 30, 2040

    granted

  8. US 10703816

    M971 chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 7, 2020 · Expires Jul 2, 2040

    granted

  9. US 10689456

    Anti-CD70 chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted

  10. US 10676528

    Thymic stromal lymphopoietin receptor-specific chimeric antigen receptors and methods using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted

  11. US 10654898

    Recombinant human/bovine parainfluenza virus 3 (B/HPIV3) expressing a chimeric RSV/BPIV3 F protein and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 19, 2020 · Expires May 14, 2040

    granted

  12. US 10640570

    Chimeric antigen receptors, compositions, and methods

    Regents of the University of Minnesota · Granted May 5, 2020 · Expires Apr 30, 2040

    granted

  13. US 10632185

    Chimeric west nile/zika viruses and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted

  14. US 10632152

    Chimeric antigen receptor and methods of use thereof

    The Regents of the University of California · Granted Apr 28, 2020 · Expires Apr 23, 2040

    granted

  15. US 10570186

    Chimeric antigen receptors (CAR) to selectively target protein complexes

    The Board of Regents of the University of Texas System · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted

  16. US 10570214

    Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 25, 2020 · Expires Feb 20, 2040

    granted

  17. US 10562952

    Anti-CD276 chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Feb 18, 2020 · Expires Feb 13, 2040

    granted

  18. US 10500264

    Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 10, 2019 · Expires Dec 5, 2039

    granted

  19. US 10449231

    Compositions and methods for dengue virus chimeric constructs in vaccines

    The Government of the United States of America as represented by the Secretary of the Deptartment of Health and Human Services · Granted Oct 22, 2019 · Expires Oct 17, 2039

    granted

  20. US 10428313

    Chimeric West Nile/Dengue viruses and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 1, 2019 · Expires Sep 26, 2039

    granted

  21. US 10392430

    Methods of making nucleic acid molecules encoding modified chimeric polypeptides with improved pharmacokinetic properties

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 27, 2019 · Expires Aug 22, 2039

    granted

  22. US 10287350

    Chimeric antigen receptors targeting CD-19

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 14, 2019 · Expires May 9, 2039

    granted

  23. US 10246505

    Chimeric antigen receptors to control HIV infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 2, 2019 · Expires Mar 28, 2039

    granted

  24. US 10202595

    Chimeric clotting factors

    BIOVERATIV THERAPEUTICS INC. · Granted Feb 12, 2019 · Expires Feb 7, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.